Researchers have uncovered the mechanisms that protect the genome from the metabolic toxin formaldehyde in AMeD, a rare congenital disorder of premature aging and myeloid leukemia development. The team used human cells and a new animal model to recapitulate AMeD symptoms and their findings open the door to new therapeutic interventions.